https://spectator.us/pfizer-warp-speed-coronavirus-vaccine/
The deal was that the Trump administration would give Pfizer $1.95 billion for 100 million doses of a coronavirus vaccine if it was completed by the end of the year. The New York Times described the partnership as ‘part of what the White House calls the Warp Speed project’ in July. Pfizer also said at the time that they did not accept federal funding for research and development because they thought dealing with government contracts would slow down their progress. Declining government funds at that time was thus more strategic than principled. The company, of course, would still feel comfortable sinking its own money into development knowing that the government had agreed to purchase its product regardless of if other vaccines became available in the meantime.
Pfizer did not reply when The Spectator asked why it is now distancing itself from the partnership. The pharmaceutical giant did issue a statement clarifying that it is in fact ‘one of various vaccine manufacturers participating in Operation Warp Speed’. It seems awfully scummy for Pfizer to publicly rebuke the Trump administration when it almost certainly intends to still sell the government its vaccines for a cool $2 billion.